Area of research
Genetics · Epidemiology
Research interest
Research interests include Glioma Diagnosis and Treatment, Meningioma and schwannoma management, Brain Metastases and Treatment, and Advanced Radiotherapy Techniques.
Single-nucleus and spatial transcriptome profiling of pancreatic cancer identifies multicellular dynamics associated with neoadjuvant treatment
Physics and biomedical challenges of cancer therapy with accelerated heavy ions
Pan-cancer Transcriptomic Predictors of Perineural Invasion Improve Occult Histopathologic Detection
Central Nervous System Cancers, Version 3.2020, NCCN Clinical Practice Guidelines in Oncology
Defining Treatment-Related Adverse Effects in Patients with Glioma: Distinctive Features of Pseudoprogression and Treatment-Induced Necrosis
Assessing the interactions between radiotherapy and antitumour immunity
Treatment-induced brain tissue necrosis: a clinical challenge in neuro-oncology
Volumetric and actuarial analysis of brain necrosis in proton therapy using a novel mixture cure model
Safety of combining radiotherapy with immune-checkpoint inhibition
“Radiobiology of Proton Therapy”: Results of an international expert workshop
Charged-particle therapy in cancer: clinical uses and future perspectives
NCCN Guidelines Insights: Central Nervous System Cancers, Version 1.2017
Imaging and extent of surgical resection predict risk of meningioma recurrence better than WHO histopathological grade
Benign meningiomas (WHO Grade I) with atypical histological features: correlation of histopathological features with clinical outcomes
Brain Tumor Cells in Circulation Are Enriched for Mesenchymal Gene Expression
Central Nervous System Cancers, Version 2.2014
It Is Time to Reevaluate the Management of Patients With Brain Metastases
Charged particle therapy—optimization, challenges and future directions
Improved tumor oxygenation and survival in glioblastoma patients who show increased blood perfusion after cediranib and chemoradiation
Central Nervous System Cancers
The accuracy of predicting survival in individual patients with cancer
Integrative Radiogenomic Profiling of Squamous Cell Lung Cancer
Neurocognitive assessment following whole brain radiation therapy and radiosurgery for patients with cerebral metastases: Table 1
Radiation Treatment for WHO Grade II and III Meningiomas